Linda Z. Penn

Also affiliated with University of Toronto, Princess Margaret Cancer Centre

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma”.

The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma

Leukemia(2020)10.1038/s41375-020-0962-2

N/A

0DataRank · unranked

36 citations

Petr Smirnov, Zhihua Li, Emily Branchard, Jenna E. van Leeuwen, Jonathan D. Licht +7 more

Recruitment of FBXO22 for targeted degradation of NSD2

Nature Chemical Biology(2024)10.1038/s41589-024-01660-y

N/A

0DataRank · unranked

59 citations

John R. Tabor, Jianping Li, Maria Kutera, Jonathan St‐Germain, Ronan P. Hanley +24 more

Structural basis of TMPRSS11D specificity and autocleavage activation

Nature Communications(2025)10.1038/s41467-025-59677-3

N/A

0DataRank · unranked

6 citations

Ryan P. Wilson, Sára Ferková, Olzhas Ilyassov, Jackie Lac, Aiping Dong +13 more